365 related articles for article (PubMed ID: 27956436)
21. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
22. Pediatric thyroid cancer: An update from the SEER database 2007-2012.
Dermody S; Walls A; Harley EH
Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():121-6. PubMed ID: 27619041
[TBL] [Abstract][Full Text] [Related]
23. When do changes in cancer survival mean progress? The insight from population incidence and mortality.
Cho H; Mariotto AB; Schwartz LM; Luo J; Woloshin S
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):187-97. PubMed ID: 25417232
[TBL] [Abstract][Full Text] [Related]
24. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates.
Frey CM; McMillen MM; Cowan CD; Horm JW; Kessler LG
J Natl Cancer Inst; 1992 Jun; 84(11):872-7. PubMed ID: 1593655
[TBL] [Abstract][Full Text] [Related]
25. Cancer Incidence Patterns in the Oldest Ages Using Expanded Age Categories from SEER Regist
